NCT02775630

Brief Summary

Bronchoscopy is an examination performed routinely in pulmonology. This exam is considered as uncomfortable by nearly 60% of patients, especially due to respiratory blocking sensation, cough and nausea it causes, despite the use of a local anesthetic. Conversely, this examination is rarely performed under general anesthesia in hospitals in France, because it lengthens the duration of the procedure, increases its cost and can be dangerous for the respiratory failure patient. Hypnosis is an altered state of consciousness between wakefulness and sleep, which can cause the patient to ignore the reality in which he is focusing his attention on his imagination, reducing his anxiety, his painful or unpleasant perceptions and their memorization. The hypnosis benefit has already been evaluated in the control of pain and anxiety in many medical situations, surgical, obstetric and dental. In endoscopy, the results are mixed. In bronchoscopy, hypnosis has, to our knowledge, not been evaluated. In a preliminary study in the endoscopy unit of the Hospital Saint Joseph, involving 66 patients, investigators showed that bronchoscopy was poorly tolerated in more than half of patients and that this poor tolerance was correlated to the level anxiety of patients, but 75% of patients surveyed would prefer the waning redo the examination in the same conditions if their health required it, rather than using a general anesthetic. Investigators then hypothesized that hypnosis would improve tolerance bronchoscopy under local anesthesia, without the need for general anesthesia.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
113

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 4, 2014

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

May 9, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 17, 2016

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 2, 2021

Completed
2.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

April 27, 2023

Status Verified

April 1, 2023

Enrollment Period

6.6 years

First QC Date

May 9, 2016

Last Update Submit

April 26, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Anxiety Questionnaire HAD (Hospital Anxiety and Depression Scale)

    At Day 0 within 30 minutes after the exam

  • Assessment of timing change of endoscopy

    At Day 0, Time laps Start at the input of the endoscopy suite and stop when the output of the endoscopy suite

Study Arms (2)

Examination under hypnosis in addition to local anesthesia

EXPERIMENTAL

Patients will have hypnosis add-on local anesthesia

Procedure: hypnosis

Examination under local anesthesia

NO INTERVENTION

Patients will receive a local anesthesia only without hypnosis

Interventions

hypnosisPROCEDURE

It will be proposed to the patient to participate in a study to assess the tolerance of Examination under hypnosis The examination is then conducted in endoscopy room. The patient will benefit from an induction technique of hypnosis by a doctor trained in hypnosis and local anesthesia performed by the endoscopist. In the control group, only local anesthesia is practiced by the endoscopist. The waning, it will ask the patient and endoscopist to complete an evaluation form tolerance of the review

Examination under hypnosis in addition to local anesthesia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Before performing a bronchoscopy under his medical care
  • No opposition to participate in the study

You may not qualify if:

  • Poor understanding of the French language
  • major hearing impairment
  • severe cognitive or psychiatric disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Groupe Hospitalier Paris Saint Joseph

Paris, Île-de-France Region, 75014, France

Location

MeSH Terms

Conditions

Respiratory System Abnormalities

Interventions

Hypnosis

Condition Hierarchy (Ancestors)

Respiratory Tract DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Stephane JOUVESHOMME

    Groupe Hospitalier Paris Saint-Joseph (FRANCE)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 9, 2016

First Posted

May 17, 2016

Study Start

July 4, 2014

Primary Completion

February 2, 2021

Study Completion

December 31, 2023

Last Updated

April 27, 2023

Record last verified: 2023-04

Locations